VIDA Companies

A Lung and Respiratory Intelligence Company. VIDA IS ACCELERATING RESPIRATORY CLINICAL TRIALS THROUGH INTELLIGENCE See How COVID-19 Asthma COPD ILD Cancer Emphysema Respiratory clinical trials are costly and inefficient, Our mission is to accelerate therapies to patients.
Investors
Connections from
Industry:
Health Care Services
Technology:
AgeTech
Estimated Revenue:
$1M to $10M
Investors Number:
4
Headquarters:
Jakarta, Jakarta Raya, Indonesia
Employee Number:
51-100
Number Of Exists:
51-100
Investor Type:
Company
Total Funding:
20400000
Founded Date:
2004-01-01
Last Funding Type:
Series C
Last Funding Date:
2020